A detailed history of Clark Estates Inc transactions in Haleon PLC stock. As of the latest transaction made, Clark Estates Inc holds 2,000,000 shares of HLN stock, worth $18.7 Million. This represents 5.51% of its overall portfolio holdings.

Number of Shares
2,000,000
Previous 2,650,000 24.53%
Holding current value
$18.7 Million
Previous $21.9 Million 3.33%
% of portfolio
5.51%
Previous 5.61%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$8.32 - $10.7 $5.41 Million - $6.96 Million
-650,000 Reduced 24.53%
2,000,000 $21.2 Million
Q4 2023

Feb 12, 2024

SELL
$7.78 - $8.62 $1.56 Million - $1.72 Million
-200,000 Reduced 7.02%
2,650,000 $21.8 Million
Q3 2023

Nov 13, 2023

SELL
$7.85 - $8.94 $1.96 Million - $2.24 Million
-250,000 Reduced 8.06%
2,850,000 $23.7 Million
Q4 2022

Feb 08, 2023

BUY
$5.96 - $8.06 $1.49 Million - $2.02 Million
250,000 Added 8.77%
3,100,000 $24.8 Million
Q3 2022

Nov 14, 2022

BUY
$5.63 - $7.5 $16 Million - $21.4 Million
2,850,000 New
2,850,000 $17.4 Million

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $43.1B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Clark Estates Inc Portfolio

Follow Clark Estates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clark Estates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Clark Estates Inc with notifications on news.